US Stock MarketDetailed Quotes

LPTX Leap Therapeutics

Watchlist
  • 2.3500
  • +0.2600+12.44%
Close Jul 12 16:00 ET
  • 2.2900
  • -0.0600-2.55%
Post 17:03 ET
89.92MMarket Cap-1880P/E (TTM)

Leap Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-65.66%14.58M
57.08%85.94M
12.72%14.84M
-2.44%14.28M
-11.95%14.36M
300.70%42.45M
31.20%54.71M
17.35%13.17M
30.14%14.64M
67.19%16.31M
Selling and administrative expenses
-6.82%3.53M
17.03%13.81M
7.77%3.14M
4.52%3.33M
24.62%3.56M
32.87%3.78M
9.59%11.8M
4.15%2.91M
30.68%3.19M
2.15%2.86M
-General and administrative expense
-6.82%3.53M
17.03%13.81M
7.77%3.14M
4.52%3.33M
24.62%3.56M
32.87%3.78M
9.59%11.8M
4.15%2.91M
30.68%3.19M
2.15%2.86M
Research and development costs
-70.99%11.3M
62.87%73.23M
5.90%11.69M
-4.95%11.5M
-20.94%11.1M
400.28%38.94M
39.82%44.97M
36.73%11.03M
20.10%12.1M
94.91%14.05M
Other operating expenses
9.56%-246K
46.32%-1.1M
102.97%23K
15.03%-554K
49.23%-298K
-635.14%-272K
-67.29%-2.05M
-316.48%-775K
48.62%-652K
-140.57%-587K
Operating profit
65.66%-14.58M
-57.08%-85.94M
-12.72%-14.84M
2.44%-14.28M
11.95%-14.36M
-300.70%-42.45M
-36.10%-54.71M
-21.41%-13.17M
-34.63%-14.64M
-73.88%-16.31M
Net non-operating interest income expense
-8.61%775K
362.34%4.03M
81.78%938K
210.60%1.08M
5,159.09%1.16M
5,400.00%848K
2,821.88%871K
17,100.00%516K
4,462.50%349K
246.67%22K
Non-operating interest income
-8.61%775K
335.35%4.03M
80.04%938K
201.11%1.08M
2,866.67%1.16M
16,860.00%848K
10,177.78%925K
10,320.00%521K
35,900.00%360K
3,800.00%39K
Non-operating interest expense
----
--0
--0
--0
--0
----
31.71%54K
150.00%5K
22.22%11K
6.25%17K
Other net income (expense)
93.77%-16K
182.07%499K
106.60%1.44M
37.92%-501K
75.03%-183K
-209.36%-257K
-60.42%-608K
2,148.39%697K
-210.38%-807K
-468.22%-733K
Gain on sale of security
93.77%-16K
99.84%-1K
34.86%940K
37.92%-501K
75.03%-183K
-209.36%-257K
-60.42%-608K
2,148.39%697K
-210.38%-807K
-468.22%-733K
Other non- operating income (expenses)
----
--500K
----
----
----
----
----
----
----
----
Income before tax
66.99%-13.82M
-49.52%-81.41M
-4.27%-12.47M
9.26%-13.7M
21.35%-13.39M
-303.46%-41.86M
-34.07%-54.45M
-10.57%-11.96M
-35.51%-15.09M
-78.71%-17.02M
Income tax
0
712.50%147K
Net income
66.99%-13.82M
-49.12%-81.41M
-3.00%-12.47M
9.26%-13.7M
21.35%-13.39M
-303.46%-41.86M
-34.52%-54.6M
-12.18%-12.1M
-35.51%-15.09M
-78.71%-17.02M
Net income continuous Operations
66.99%-13.82M
-49.12%-81.41M
-3.00%-12.47M
9.26%-13.7M
21.35%-13.39M
-303.46%-41.86M
-34.52%-54.6M
-12.18%-12.1M
-35.51%-15.09M
-78.71%-17.02M
Minority interest income
Net income attributable to the parent company
66.99%-13.82M
-49.12%-81.41M
-3.00%-12.47M
9.26%-13.7M
21.35%-13.39M
-303.46%-41.86M
-34.52%-54.6M
-12.18%-12.1M
-35.51%-15.09M
-78.71%-17.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
66.99%-13.82M
-49.12%-81.41M
-3.00%-12.47M
9.26%-13.7M
21.35%-13.39M
-303.46%-41.86M
-34.52%-54.6M
-12.18%-12.1M
-35.51%-15.09M
-78.71%-17.02M
Basic earnings per share
84.26%-0.51
17.43%-3.98
81.82%-0.2
61.65%-0.51
39.33%-0.91
-260.00%-3.24
-2.55%-4.82
-10.00%-1.1
5.00%-1.33
-25.00%-1.5
Diluted earnings per share
84.26%-0.51
17.43%-3.98
81.82%-0.2
61.65%-0.51
39.33%-0.91
-260.00%-3.24
-2.55%-4.82
-10.00%-1.1
5.00%-1.33
-25.00%-1.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -65.66%14.58M57.08%85.94M12.72%14.84M-2.44%14.28M-11.95%14.36M300.70%42.45M31.20%54.71M17.35%13.17M30.14%14.64M67.19%16.31M
Selling and administrative expenses -6.82%3.53M17.03%13.81M7.77%3.14M4.52%3.33M24.62%3.56M32.87%3.78M9.59%11.8M4.15%2.91M30.68%3.19M2.15%2.86M
-General and administrative expense -6.82%3.53M17.03%13.81M7.77%3.14M4.52%3.33M24.62%3.56M32.87%3.78M9.59%11.8M4.15%2.91M30.68%3.19M2.15%2.86M
Research and development costs -70.99%11.3M62.87%73.23M5.90%11.69M-4.95%11.5M-20.94%11.1M400.28%38.94M39.82%44.97M36.73%11.03M20.10%12.1M94.91%14.05M
Other operating expenses 9.56%-246K46.32%-1.1M102.97%23K15.03%-554K49.23%-298K-635.14%-272K-67.29%-2.05M-316.48%-775K48.62%-652K-140.57%-587K
Operating profit 65.66%-14.58M-57.08%-85.94M-12.72%-14.84M2.44%-14.28M11.95%-14.36M-300.70%-42.45M-36.10%-54.71M-21.41%-13.17M-34.63%-14.64M-73.88%-16.31M
Net non-operating interest income expense -8.61%775K362.34%4.03M81.78%938K210.60%1.08M5,159.09%1.16M5,400.00%848K2,821.88%871K17,100.00%516K4,462.50%349K246.67%22K
Non-operating interest income -8.61%775K335.35%4.03M80.04%938K201.11%1.08M2,866.67%1.16M16,860.00%848K10,177.78%925K10,320.00%521K35,900.00%360K3,800.00%39K
Non-operating interest expense ------0--0--0--0----31.71%54K150.00%5K22.22%11K6.25%17K
Other net income (expense) 93.77%-16K182.07%499K106.60%1.44M37.92%-501K75.03%-183K-209.36%-257K-60.42%-608K2,148.39%697K-210.38%-807K-468.22%-733K
Gain on sale of security 93.77%-16K99.84%-1K34.86%940K37.92%-501K75.03%-183K-209.36%-257K-60.42%-608K2,148.39%697K-210.38%-807K-468.22%-733K
Other non- operating income (expenses) ------500K--------------------------------
Income before tax 66.99%-13.82M-49.52%-81.41M-4.27%-12.47M9.26%-13.7M21.35%-13.39M-303.46%-41.86M-34.07%-54.45M-10.57%-11.96M-35.51%-15.09M-78.71%-17.02M
Income tax 0712.50%147K
Net income 66.99%-13.82M-49.12%-81.41M-3.00%-12.47M9.26%-13.7M21.35%-13.39M-303.46%-41.86M-34.52%-54.6M-12.18%-12.1M-35.51%-15.09M-78.71%-17.02M
Net income continuous Operations 66.99%-13.82M-49.12%-81.41M-3.00%-12.47M9.26%-13.7M21.35%-13.39M-303.46%-41.86M-34.52%-54.6M-12.18%-12.1M-35.51%-15.09M-78.71%-17.02M
Minority interest income
Net income attributable to the parent company 66.99%-13.82M-49.12%-81.41M-3.00%-12.47M9.26%-13.7M21.35%-13.39M-303.46%-41.86M-34.52%-54.6M-12.18%-12.1M-35.51%-15.09M-78.71%-17.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 66.99%-13.82M-49.12%-81.41M-3.00%-12.47M9.26%-13.7M21.35%-13.39M-303.46%-41.86M-34.52%-54.6M-12.18%-12.1M-35.51%-15.09M-78.71%-17.02M
Basic earnings per share 84.26%-0.5117.43%-3.9881.82%-0.261.65%-0.5139.33%-0.91-260.00%-3.24-2.55%-4.82-10.00%-1.15.00%-1.33-25.00%-1.5
Diluted earnings per share 84.26%-0.5117.43%-3.9881.82%-0.261.65%-0.5139.33%-0.91-260.00%-3.24-2.55%-4.82-10.00%-1.15.00%-1.33-25.00%-1.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg